Advertisement

Screening e studio delle epatopatie croniche nei donatori di sangue

  • Alessandra BerzuiniEmail author
  • Alessandro Gerosa
  • Piergiorgio Duca
  • Agostino Colli
  • Daniele Prati
Chapter

Riassunto

I donatori di sangue in occasione della donazione, e quindi potenzialmente più volte all’anno, vengono sottoposti a controlli clinici finalizzati a valutare la sicurezza del sangue donato. Il controllo sanitario rappresenta spesso una delle motivazioni principali alla donazione di sangue, ed è elemento importante per la fidelizzazione del donatore. Questi controlli (clinici, anamnestici, morfometrici, comportamentali e biochimici) costituiscono un momento estremamente importante per la salute del donatore, in quanto permettono di individuare non solo patologie in atto, ma anche fattori di rischio che possono portare all’insorgenza in futuro di eventi anche gravi. Per molti donatori di sangue, specialmente se giovani e in buona salute, il momento della donazione rappresenta pressoché l’unico controllo sanitario al quale si sottopongono.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Bibliografia

  1. American Association for the Study of Liver Disease (AASLD) (2007) Practice Guidelines: Chronic Hepatitis B. Hepatology 45:507–539CrossRefGoogle Scholar
  2. Associazione Italiana Studio Fegato (AISF) (2007) Epidemiologia delle epatopatie acute e croniche in Italia. http://webaisf.org/commconl.htm
  3. Capelli C, Prati D, Bosoni P et al (1997) Sexual transmission of hepatitis C virus to a repeat blood donor. Transfusion 37:436–440PubMedCrossRefGoogle Scholar
  4. Chen BP, Rumi MG, Colombo M et al (1999) TT virus is present in a high frequency in Italian hemophilic patients transfused with plasma-derived clotting factor concentrates. Blood 94:4333–4336PubMedGoogle Scholar
  5. De Filippi F, Colombo M, Rumi MG et al (1997) High rates of hepatitis G virus infection in multitransfused patients with hemophilia. Blood 90:4634–4637PubMedGoogle Scholar
  6. Kim HC, Nam CM, Jee SH et al (2004) Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study. BMJ 328:983PubMedCrossRefGoogle Scholar
  7. Prati D, Capelli C, Silvani C et al (1997) The incidence and risk factors of community-acquired hepatitis C in a cohort of Italian blood donors. Hepatology 25:702–704PubMedCrossRefGoogle Scholar
  8. Prati D, Capelli C, Zanella A et al (1996) Influence of different hepatitis C virus genotypes on the course of asymptomatic hepatitis C virus infection. Gastroenterology 110:178–183PubMedCrossRefGoogle Scholar
  9. Prati D, Capelli C, Zanella A et al (1997) Asymptomatic hepatitis G virus infection in blood donors. Transfusion 37:1200–1204PubMedCrossRefGoogle Scholar
  10. Prati D, Colli A, Conte D (2003) Healthy ranges for alanine aminotransferase. Ann Intern Med 138:156–157Google Scholar
  11. Prati D, Gerosa A, Porretti L (2006) Occult HBV infection and blood transfusion. J Hepatol 44:818PubMedCrossRefGoogle Scholar
  12. Prati D, Lin YH, De Mattei C et al for the Cooleycare Cooperative Group (1999) A prospective study on TT virus (TTV) infection in transfusion-dependent patients with beta-thalassemia. Blood 93:1502–1505PubMedGoogle Scholar
  13. Prati D, Shiffman ML, Diago M et al (2006) Viral and metabolic factors influencing alanine aminotransferase activity in patients with chronic hepatitis C. J Hepatol 44:679–685PubMedCrossRefGoogle Scholar
  14. Prati D, Taioli E, Zanella A (2002) Updated definitions of healthy ranges for serum alanine amino-transferase levels. Ann Intern Med 137:1–10PubMedGoogle Scholar
  15. Prati D, Zanella A, Bosoni P et al for the Cooleycare cooperative group (1998) The incidence and natural course of transfusion-associated GB virus C/hepatitis G virus infection in a cohort of thalassemic patients. Blood 91:774–777PubMedGoogle Scholar
  16. Prati D, Zanella A, De Mattei C et al (1999) Chronic hepatitis C virus infection and primary cutaneous B-cell lymphoma. Br J Haematol 105:841PubMedCrossRefGoogle Scholar
  17. Prati D, Zanella A, Zanuso F for the Donor Surveillance Study Group (2000) Sustained response to interferon alfa-2a monotherapy of young blood donors with minimal to mild chronic hepatitis C. J Vir Hepat 7:352–360CrossRefGoogle Scholar
  18. Puoti C, Guido M, Mangia A (2003) The Committee on HCV carriers with normal aminotransferase levels of the Italian Association for the Study of the Liver. Clinical management of HCV carriers with normal aminotransferase levels. Dig Liv Dis 35:362–369CrossRefGoogle Scholar
  19. Rockey DC (2008) Noninvasive assessment of liver fibrosis and portal hypertension with transient elastography. Gastroenterology 134:8–14PubMedCrossRefGoogle Scholar
  20. Tosti ME, Solinas S, Prati D et al (2002) An estimate of the current risk of transmitting blood-borne infections through blood transfusion in Italy. Br J Haematol 117:215–219PubMedCrossRefGoogle Scholar
  21. Zanella A, Conte D, Prati D et al (1995) Hepatitis C virus RNA and liver histology in blood donors reactive to a single antigen by second generation recombinant immunoblot assay. Hepatology 21: 913–917PubMedGoogle Scholar
  22. Zeuzem S, Alberti A, Rosenberg W et al (2006) Review article: management of patients with chronic hepatitis C virus infection and “normal” alanine aminotransferase activity. Aliment Pharmacol Ther 24:1133–1149PubMedCrossRefGoogle Scholar
  23. Zeuzem S, Diago M, Gane E for the PEGASYS Study NR16071 Investigator Group (2004) Peginterferon alfa-2a (40KD) and ribavirin in patients with chronic hepatitis C and normal aminotransferase levels. Gastroenterology 127:1724–1732PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2011

Authors and Affiliations

  • Alessandra Berzuini
    • 1
    Email author
  • Alessandro Gerosa
    • 1
  • Piergiorgio Duca
    • 2
  • Agostino Colli
    • 3
  • Daniele Prati
    • 1
  1. 1.Dipartimento di Medicina Trasfusionale ed EmatologiaOspedale A. ManzoniLeccoItaly
  2. 2.Istituto di Statistica e BiometriaUniversità degli Studi, Ospedale SaccoMilanoItaly
  3. 3.Dipartimento di MedicinaOspedale A. ManzoniLeccoItaly

Personalised recommendations